Cogentix Medical, Inc. (NASDAQ:CGNT) was a big mover last session, as its shares rose over 5% on the day. The move came after the company delivered robust second-quarter 2017 results. This led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 47% in the past one-month time frame.
The company has seen one positive estimate revision in the last 30 days and its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Cognetix currently carries a Zacks Rank #2 (Buy).
Another top-ranked stock worth considering in the Medical – Instruments space is Edwards Lifesciences Corporation (NYSE:EW) sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
5 Trades Could Profit ""Big-League"" from Trump Policies
If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.
Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>
Cogentix Medical, Inc. (CGNT): Free Stock Analysis Report
Edwards Lifesciences Corporation (EW): Free Stock Analysis Report
Original post
Zacks Investment Research